Prolonged Emergence from General Anesthesia with Remimazolam; Retrospective Observational Study

Prolonged Emergence from General Anesthesia with Remimazolam; Retrospective Observational Study - Prolonged Emergence from General Anesthesia with Remimazolam; Retrospective Observational Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046549

Enrollment

100

Registered

2022-01-05

Start date

2020-11-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients undergoing elective surgery under general anesthesia with remimazolam

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients undergoing elective surgery under general anesthesia with remimazolam

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
predictive plasma concentrations of remimazolam at the end of remimazolam infusion and upon at the extubation, the total dose of remimazolam	—

Secondary

Measure	Time frame
age, sex, height, body weight, body mass index (BMI), plasma albumin concentration, ASA class, duration of surgery, and total duration of general anesthesia	—

Countries

Japan

Contacts

Public ContactMichiyoshi Sanuki

National Hospital Organization Kure Medical Center and Chugoku Cancer Center Department of Anesthesiology

msanuki@ff.iij4u.or.jp0823-22-3111

Outcome results